KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) FCF Margin (2016 - 2025)

Historic FCF Margin for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to 1.88%.

  • Staar Surgical's FCF Margin rose 46100.0% to 1.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.15%, marking a year-over-year decrease of 248500.0%. This contributed to the annual value of 2.44% for FY2024, which is 13300.0% down from last year.
  • Latest data reveals that Staar Surgical reported FCF Margin of 1.88% as of Q3 2025, which was up 46100.0% from 65.53% recorded in Q2 2025.
  • Staar Surgical's 5-year FCF Margin high stood at 37.87% for Q4 2023, and its period low was 65.53% during Q2 2025.
  • Its 5-year average for FCF Margin is 0.5%, with a median of 0.12% in 2022.
  • As far as peak fluctuations go, Staar Surgical's FCF Margin soared by 395100bps in 2023, and later crashed by -487100bps in 2025.
  • Over the past 5 years, Staar Surgical's FCF Margin (Quarter) stood at 6.46% in 2021, then plummeted by -126bps to 1.65% in 2022, then soared by 2399bps to 37.87% in 2023, then plummeted by -127bps to 10.38% in 2024, then skyrocketed by 118bps to 1.88% in 2025.
  • Its last three reported values are 1.88% in Q3 2025, 65.53% for Q2 2025, and 16.91% during Q1 2025.